We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
OneMain Financial
OMF
$7.27B
| $52.6M | 0.07% |
1,579,028
-192,547
| -11% | -$6.83M |
|
227
United Therapeutics
UTHR
$22.7B
| $52.6M | 0.07% |
188,974
+37,158
| +24% | +$9.38M |
|
228
Performance Food Group
PFGC
$17.9B
| $52.5M | 0.07% |
+899,313
| New | +$49M |
|
229
Teleflex
TFX
$5.89B
| $52.3M | 0.07% |
209,350
-14,441
| -6% | -$3.19M |
|
230
Baxter International
BAX
$14.4B
| $52.2M | 0.07% |
1,023,788
+134,943
| +15% | +$7.25M |
|
|
LSXMK
231
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $52.1M | 0.07% |
1,719,360
+284,145
| +20% | +$9.09M |
|
232
NetApp
NTAP
$39B
| $51.7M | 0.07% |
861,071
-871,957
| -50% | -$57.8M |
|
233
Gold Fields
GFI
$36.8B
| $51.7M | 0.07% |
+4,995,504
| New | +$48.4M |
|
234
Bath & Body Works
BBWI
$3.89B
| $51.6M | 0.07% |
1,225,086
-949,683
| -44% | -$35.4M |
|
235
Hasbro
HAS
$13.3B
| $50.6M | 0.07% |
829,829
+361,825
| +77% | +$22.6M |
|
236
Itaú Unibanco
ITUB
$86.9B
| $50.6M | 0.07% |
12,171,344
+12,159,108
| +99,372% | +$55.2M |
|
237
Vail Resorts
MTN
$5.21B
| $50M | 0.07% |
209,566
+47,649
| +29% | +$11.2M |
|
238
Dow Inc
DOW
$22.1B
| $49.5M | 0.07% |
982,200
+975,316
| +14,168% | +$47.6M |
|
239
Haemonetics
HAE
$3.94B
| $49.3M | 0.07% |
627,318
+454,459
| +263% | +$36.5M |
|
240
W.W. Grainger
GWW
$61.1B
| $49.3M | 0.07% |
88,596
+48,449
| +121% | +$27.3M |
|
241
Bloomin' Brands
BLMN
$944M
| $49.2M | 0.07% |
2,445,864
+132,898
| +6% | +$2.88M |
|
242
Signet Jewelers
SIG
$3.67B
| $48.9M | 0.07% |
719,686
-164,092
| -19% | -$10.4M |
|
243
Dollar General
DG
$27B
| $48.4M | 0.07% |
196,711
+129,222
| +191% | +$32M |
|
|
WCN
244
Waste Connections
WCN
$41.8B
| $48.4M | 0.07% |
365,200
+160,746
| +79% | +$21.9M |
|
245
WEX
WEX
$6.35B
| $48.1M | 0.07% |
293,903
+71,071
| +32% | +$11.1M |
|
246
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $47.7M | 0.07% |
7,934,052
+518,812
| +7% | +$2.8M |
|
247
Ford
F
$55.8B
| $47.6M | 0.07% |
4,088,826
-1,413,245
| -26% | -$18.2M |
|
248
Genpact
G
$5.74B
| $47.2M | 0.07% |
1,019,776
+156,098
| +18% | +$7.1M |
|
|
COOP
249
DELISTED
Mr. Cooper
COOP
| $46.8M | 0.07% |
1,166,027
-119,267
| -9% | -$5.04M |
|
250
Mercado Libre
MELI
$92.5B
| $46.8M | 0.07% |
55,291
+14,224
| +35% | +$12.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.